Jonathan Tobin

Partner

2021

I'm focused on leading investments in biotech companies globally. jtobin@bcpvc.com

Investor-in-Residence

2023

As investor-in-residence I am advising the CRH Seed fund team on their early stage investments in start-ups based on the ground breaking research emerging from Cancer Research UK laboratories.

Non Executive Director

2024

Non-exec director representing Cancer Research Horizons

Non Executive Director

2023

Non Executive Director

2021

Non Executive Director

2022

First-in-class anti-GDF15 mAb in Phase 2 in solid tumour patients

Non Executive Director

2022

Non Executive Director

2022

Member of the Investment Advisory Committee

2020

KHAN-I is a new fund backed by the Max Planck Foundation, European Investment Fund, and Austrian government to back early stage drug discovery projects originating from Germany and Austria to create new biotech opportunities.

Commercial Partnerships Advisor

2021 - 2021

Large consultancy project advising Genomics England on part of their commercial strategy